NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cincinnati Bell Inc (NYSE:CBB), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Shutterstock, Inc. (NYSE:SSTK), Kopin Corporation (NASDAQ:KOPN), Lands' End, Inc. (NASDAQ:LE), and Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CBB DOWNLOAD: http://Fundamental-Markets.com/register/?so=CBB
BCRX DOWNLOAD: http://Fundamental-Markets.com/register/?so=BCRX
SSTK DOWNLOAD: http://Fundamental-Markets.com/register/?so=SSTK
KOPN DOWNLOAD: http://Fundamental-Markets.com/register/?so=KOPN
LE DOWNLOAD: http://Fundamental-Markets.com/register/?so=LE
PIRS DOWNLOAD: http://Fundamental-Markets.com/register/?so=PIRS

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Cincinnati Bell Inc (NYSE:CBB), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Shutterstock, Inc. (NYSE:SSTK), Kopin Corporation (NASDAQ:KOPN), Lands' End, Inc. (NASDAQ:LE), and Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 13th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CINCINNATI BELL INC (CBB) REPORT OVERVIEW

Cincinnati Bell's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Cincinnati Bell reported revenue of $296.80MM vs $259.40MM (up 14.42%) and basic earnings per share -$0.39 vs -$0.01. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cincinnati Bell reported revenue of $1,288.50MM vs $1,185.80MM (up 8.66%) and basic earnings per share $0.59 vs $2.18 (down 72.94%). Cincinnati Bell is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.03. The estimated EPS forecast for the next fiscal year is -$0.46 and is expected to report on February 21st, 2019.

To read the full Cincinnati Bell Inc (CBB) report, download it here: http://Fundamental-Markets.com/register/?so=CBB

-----------------------------------------

BIOCRYST PHARMACEUTICALS, INC. (BCRX) REPORT OVERVIEW

BioCryst Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, BioCryst Pharmaceuticals reported revenue of $12.49MM vs $3.10MM (up 303.16%) and basic earnings per share -$0.19 vs -$0.21. For the twelve months ended December 31st, 2017 vs December 31st, 2016, BioCryst Pharmaceuticals reported revenue of $25.19MM vs $26.35MM (down 4.43%) and basic earnings per share -$0.78 vs -$0.75. BioCryst Pharmaceuticals is expected to report earnings on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.18. The estimated EPS forecast for the next fiscal year is -$0.91 and is expected to report on February 26th, 2019.

To read the full BioCryst Pharmaceuticals, Inc. (BCRX) report, download it here: http://Fundamental-Markets.com/register/?so=BCRX

-----------------------------------------

SHUTTERSTOCK, INC. (SSTK) REPORT OVERVIEW

Shutterstock's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Shutterstock reported revenue of $156.58MM vs $134.00MM (up 16.86%) and basic earnings per share -$0.01 vs $0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Shutterstock reported revenue of $557.11MM vs $494.32MM (up 12.70%) and basic earnings per share $0.48 vs $0.93 (down 48.39%). Shutterstock is expected to report earnings on October 30th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.18. The estimated EPS forecast for the next fiscal year is $1.15 and is expected to report on February 28th, 2019.

To read the full Shutterstock, Inc. (SSTK) report, download it here: http://Fundamental-Markets.com/register/?so=SSTK

-----------------------------------------

KOPIN CORPORATION (KOPN) REPORT OVERVIEW

Kopin's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Kopin reported revenue of $5.94MM vs $5.93MM (up 0.28%) and basic earnings per share -$0.13 vs -$0.10. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Kopin reported revenue of $27.84MM vs $22.64MM (up 22.96%) and basic earnings per share -$0.36 vs -$0.37. Kopin is expected to report earnings on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018.

To read the full Kopin Corporation (KOPN) report, download it here: http://Fundamental-Markets.com/register/?so=KOPN

-----------------------------------------

LANDS' END, INC. (LE) REPORT OVERVIEW

Lands' End's Recent Financial Performance

For the three months ended April 30th, 2018 vs April 30th, 2017, Lands' End reported revenue of $299.83MM vs $268.37MM (up 11.72%) and basic earnings per share -$0.08 vs -$0.24. For the twelve months ended January 31st, 2018 vs January 31st, 2017, Lands' End reported revenue of $1,406.68MM vs $1,335.76MM (up 5.31%) and basic earnings per share $0.88 vs -$3.43. Lands' End is expected to report earnings on August 30th, 2018. The report will be for the fiscal period ending July 31st, 2018. The reported EPS for the same quarter last year was -$0.12.

To read the full Lands' End, Inc. (LE) report, download it here: http://Fundamental-Markets.com/register/?so=LE

-----------------------------------------

PIERIS PHARMACEUTICALS, INC. (PIRS) REPORT OVERVIEW

Pieris Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Pieris Pharmaceuticals reported revenue of $11.69MM vs $1.85MM (up 530.92%) and basic earnings per share -$0.00 vs -$0.23. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Pieris Pharmaceuticals reported revenue of $25.28MM vs $5.83MM (up 333.46%) and basic earnings per share -$0.40 vs -$0.55. Pieris Pharmaceuticals is expected to report earnings on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.16. The estimated EPS forecast for the next fiscal year is -$0.76 and is expected to report on March 8th, 2019.

To read the full Pieris Pharmaceuticals, Inc. (PIRS) report, download it here: http://Fundamental-Markets.com/register/?so=PIRS

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.